Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04522687

Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer

Observation of the Impact of Radiotherapy With or Without Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets for Patients With Thoracic Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Shanghai Cancer Hospital, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is an observation, single center study to evaluate the alternations and prognostic value of peripheral blood lymphocyte (PBL) in patients diagnosed with thoracic cancers, including lung cancer, esophageal squamous cell carcinoma and thymic epithelial carcinoma underwent radiotherapy with or without chemotherapy.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2023-12-01
Completion
2026-12-01
First posted
2020-08-21
Last updated
2020-08-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04522687. Inclusion in this directory is not an endorsement.